Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including notable changes for Iovance Biotherapeutics, Southwest Airlines, Ball Corporation, Alaska Air Group, W.W. Grainger, DraftKings, ADC Therapeutics, Hudson Pacific Properties, JetBlue Airways, and Synopsys. These adjustments reflect analysts' latest views on these companies' stock performance potential.
February 20, 2024 | 1:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. raised ADC Therapeutics' price target from $3 to $9, maintaining a Buy rating.
The substantial price target increase for ADC Therapeutics indicates a strong positive outlook, which could lead to increased investor interest and a short-term price rise.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Deutsche Bank upgraded Alaska Air Group from Hold to Buy, increasing the price target from $44 to $51.
The upgrade and higher price target for Alaska Air Group by Deutsche Bank could drive investor optimism and a short-term uptick in the stock's price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
RBC Capital upgraded Ball Corporation from Sector Perform to Outperform, raising the price target from $61 to $74.
The upgrade to Outperform and a significant price target increase for Ball Corporation suggest strong future performance, likely leading to a positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Needham raised DraftKings' price target from $50 to $54, maintaining a Buy rating.
The price target increase for DraftKings by Needham suggests continued confidence in the company's growth, potentially leading to a short-term stock price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Chardan Capital raised Iovance Biotherapeutics' price target from $29 to $34, maintaining a Buy rating.
The increase in price target by Chardan Capital suggests a positive outlook on Iovance Biotherapeutics, potentially leading to increased investor interest and a short-term price rise.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Deutsche Bank upgraded JetBlue Airways from Hold to Buy, raising the price target from $4 to $9.
The upgrade and price target increase for JetBlue Airways by Deutsche Bank indicate a positive shift in outlook, likely leading to a short-term positive impact on the stock's price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Bernstein upgraded Southwest Airlines from Underperform to Market Perform and raised the price target from $26 to $32.
The upgrade and price target increase for Southwest Airlines by Bernstein indicate a more favorable outlook, which could lead to short-term stock appreciation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Rosenblatt raised Synopsys' price target from $570 to $615, maintaining a Buy rating.
The price target increase for Synopsys by Rosenblatt suggests continued confidence in the company's prospects, potentially leading to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
Loop Capital downgraded W.W. Grainger from Buy to Hold, but raised the price target from $925 to $1,000.
Despite the downgrade to Hold, the increased price target for W.W. Grainger indicates a positive valuation adjustment, likely resulting in a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Wedbush downgraded Hudson Pacific Properties from Outperform to Neutral, cutting the price target from $11 to $7.5.
The downgrade and price target reduction for Hudson Pacific Properties by Wedbush suggest a less favorable outlook, potentially leading to a short-term decline in stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90